Showing results (41-50 of 280) with videos related to
Sort By:
Pageof 28
Pharmacology Research & Perspectives|December 16, 2014
Antitumor activity of (R,R')-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouseMichel Bernier, Rajib K Paul, Katina S S Dossou, et al.Biochimica Et Biophysica Acta|March 23, 2010
Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational statesHugo R Arias, Avraham Rosenberg, Dominik Feuerbach, et al.Biochemical Pharmacology|December 21, 2013
(R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motilityRajib K Paul, Artur Wnorowski, Isabel Gonzalez-Mariscal, et al.Brain Sciences|January 24, 2025
A Pilot Proteomic Analysis of Huntington's Disease by Functional CapacityAndrew McGarry, Ruin MoaddelNatural Product Reports|July 2, 2016
Comparison of analytical techniques for the identification of bioactive compounds from natural productsŁukasz Cieśla, Ruin MoaddelEuropean Journal of Pharmacology|November 28, 2012
Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptorsRuin Moaddel, Galia Abdrakhmanova, Joanna Kozak, et al.British Journal of Clinical Pharmacology|February 3, 2012
Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depressionXiaochen Zhao, Swarajya Lakshmi Vattem Venkata, Ruin Moaddel, et al.Human Psychopharmacology|October 31, 2002
The therapeutic promise of single enantiomers: introductionIrving W. WainerAnesthesiology|June 18, 2014
(R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin functionRajib K Paul, Nagendra S Singh, Mohammed Khadeer, et al.Pageof 28